1. Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically localized prostate cancer: AUA/ASTRO Guideline 2022. Accessed January 30, 2024. 〈https://www.auanet.org/documents/Guidelines/PDF/Localized%20Prostat%20Cancer%20Guideline.pdf〉.
2. Mottet N, Cornford P, van den Bergh RCN, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on prostate cancer. Accessed January 30, 2024. 〈https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2023_2023-06-13-141145.pdf〉.
3. Schaeffer EM, Srinivas S, Adra N, et al. National Comprehensive Cancer Network (NCCN) Guidelines version 4.2023. Prostate cancer. Accessed January 30, 2024. 〈https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf〉.
4. PSMA theragnostics for metastatic castration resistant prostate cancer;Song;Transl Oncol,2022
5. Reawakening of nuclear medicine through molecular imaging: quantitative theranostics and PSMA PET;Civelek;Radiology,2023